221 – 230 of 296
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Vaccination against atherosclerosis? Induction of atheroprotective immunity
(
- Contribution to journal › Scientific review
-
Mark
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Shifting to new targets in pharmacological prevention of cardiovascular diseases
(
- Contribution to journal › Debate/Note/Editorial
- 2008
-
Mark
Athero-protective effects of a human apoB-100 related peptide vaccine in apoE-/- mice are modulated by peptide dose and time of initiation of high fat diet
2008) American College of Cardiology 57th Annual Scientific Session In Journal of the American College of Cardiology 51(10, Suppl. 1). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction
(
- Contribution to journal › Article
-
Mark
Inflammation and immunity in diabetic vascular complications.
(
- Contribution to journal › Article
-
Mark
Cystatin C and cathepsins in cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages.
(
- Contribution to journal › Article
-
Mark
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men
(
- Contribution to journal › Article
-
Mark
Evaluation of the T cell response to apolipoprotein B100 (ApoB100): A new opportunity for immunotherapy against atherosclerosis
(
- Contribution to journal › Published meeting abstract